Biliverdin Reductase A is a major determinant of neuroprotective Nrf2 signaling is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Heart Association and Paul Allen Foundation Initiative in Brain Health and Cognitive Impairment
Grant: 19PABH134580006
NIH/NIA
Grant: 1R01AG071512
NIH/NIA
Grant: 1R21AG073684
NIH/NIA
Grant: AG077396
NIH/NIA
Grant: RO1AGs066707
NIH/NIA
Grant: 1 U01 AG073323
NIH NIDA
Grant: P50 DA044123
Catalyst Award
Grant: Johns Hopkins University
Department of Defense
Grant: HT94252310443
NIH
Grant: P01CA236778
Department of Veterans Affairs Merit Award
Grant: I01BX005976
The Meisel & Pesses Family Foundation
The Leonard Krieger Fund of the Cleveland Foundation
The Lincoln Neurotherapeutics Research Fund
The Wick Foundation
The Valour Foundation
the Rebecca E. Barchas, MD, Professor in Translational Psychiatry of Case Western Reserve University
Division of Intramural Research of the National Library of Medicine at the National Institutes of Health
Morley-Mather Chair in Neuropsychiatry of University Hospitals of Cleveland Medical Center
Intelligenomica LLC
Fields of Study
Keywords
Sustainable Development Goals